Kevin Muhlendorf Quoted in Coverage of Insider-Trading Allegations Related to Coronavirus

March 23, 2020

Kevin B. Muhlendorf, partner in Wiley’s White Collar Defense & Government Investigations Practice, was quoted in a March 20 Bloomberg Law article about allegations that some U.S. Senators conducted insider trading based on information from non-public briefings on the spread of coronavirus disease (COVID-19). Concerns have been raised that corporate executives and directors could also trade on such knowledge, according to the article.

Mr. Muhlendorf told Bloomberg Law that insider trading issues could arise with government employees tasked with overseeing drug approvals or Medicare coverage as companies test out treatments for coronavirus.

He said insider-trading investigations are “fact-intensive” and warned against assuming any wrongdoing. “Just because the trading happened doesn’t mean something wrong happened,” Mr. Muhlendorf said.

To read the Bloomberg Law article, click here (subscription required).